Wysocki MT, Gonciarz M, Puła B. Treatment refractory mast cell leukemia with dominant gastrointestinal manifestation and concomitant skin symptoms: A case report. World J Clin Cases 2024; 12(20): 4317-4324 [DOI: 10.12998/wjcc.v12.i20.4317]
Corresponding Author of This Article
Maciej Tomasz Wysocki, Department of Gastroenterology and Internal Medicine, Military Institute of Medicine-National Research Institute, 128 Szaserow Street, Warsaw 04-141, Poland maciejtwysocki@gmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Jul 16, 2024; 12(20): 4317-4324 Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4317
Treatment refractory mast cell leukemia with dominant gastrointestinal manifestation and concomitant skin symptoms: A case report
Maciej Tomasz Wysocki, Maciej Gonciarz, Bartosz Puła
Maciej Tomasz Wysocki, Maciej Gonciarz, Department of Gastroenterology and Internal Medicine, Military Institute of Medicine-National Research Institute, Warsaw 04-141, Poland
Bartosz Puła, Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw 02-776, Poland
Author contributions: Wysocki MT and Gonciarz M contributed to manuscript writing, editing, and data collection; Puła B contributed to manuscript writing, conceptualization and supervision; all authors have read and approved the final manuscript.
Informed consent statement: Informed consent was obtained from the Patient’s relatives for publication of this report.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Maciej Tomasz Wysocki, Department of Gastroenterology and Internal Medicine, Military Institute of Medicine-National Research Institute, 128 Szaserow Street, Warsaw 04-141, Poland maciejtwysocki@gmail.com
Received: January 28, 2024 Revised: April 29, 2024 Accepted: May 22, 2024 Published online: July 16, 2024 Processing time: 153 Days and 14.4 Hours
Core Tip
Core Tip: Mastocytosis is a group of neoplastic diseases characterized by excessive proliferation and infiltration of pathologic mastocytes into many organs in the human body. The clinical course of the illness may vary from indolent types, with average life expectancy, to advanced severe forms associated with poor prognosis. A disease may present with plenty of unspecific symptoms resulting in a long-lasting diagnostic process. We report a rare case of mast cell leukemia (MCL) in a 46-year-old female with weakness, unintentional weight loss, spine pain, vomiting, diarrhea, and epigastric pain occurring within several months before hospitalization. Although MCL is still associated with a high morbidity index, other less aggressive forms of systemic mastocytosis may be successfully treated with chemotherapy.
